RBM17 and acute myeloid leukemia: To confirm this finding, we performed an O-propargyl-puromycin (OPP) based protein synthesis assay and detected significantly decreased mRNA translation activity in both RBM17- and EIF4A2-knockdown AML cells, respectively (Fig. 7j).